Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

NCT02304484 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
770
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen